i2 Summit
Meeting Evaluation and Credit Reporting System
Travel Groups
New Pharmacology Program
Interactive Maintenance of Certification Program
Special ACC-NCDR® Program
Non-ACC Sponsored Events
Search REAL-TIME Program Planner
Abstract & Speaker Information
Policies & Procedures

The abstract submission site is closed.

The Program Committees invites you to submit abstracts of original investigations for consideration in the 55th Annual Scientific Session and the Innovation in Intervention: i2 Summit 2006. There will be a separate submission system for each meeting. Each abstract submitted will be peer-reviewed by a panel of reviewers. More than 2,000 abstracts will be selected for presentation, March 11-14, 2006, in Atlanta, Georgia, U.S.A.

New Abstract Category for ACC.06: Innovative Models for Practice, Education or Research
Priority will be given to submissions that demonstrate a team-based approach to cardiac care or include
nonphysician professionals.

Late-Breaking Clinical Trials: Separate submission process available beginning Thursday, November 17, 2005, through Wednesday, January 5, 2006, 11:59 p.m. Central Time (CT).

General Information

  • The majority of accepted abstracts will be scheduled as either 10-minute oral presentations or three-and-one-half-hour poster presentations. The Program Committee will determine format, based on the abstract topic and relationship to others submitted.
  • All abstract presentations and question-and-answer periods will be in English.
  • Abstracts selected will be published exactly as submitted in a 2006 supplement(s) of the Journal of the American College of Cardiology. The text of the abstracts will be available online in advance of the meeting to coincide with the JACC supplement date. Abstract title, authors, and up to two institutions with city, state, and country will be published in the onsite programs.
  • Investigators need not be ACC members to participate.
  • There is a $15 processing fee for each abstract submitted payable online by credit card only. Purchase orders, checks, and electronic bank transfers will not be accepted. This fee is non-refundable and used to cover the cost of submission and processing.
  • The College is unable to reimburse Annual Scientific Session and i2 Summit faculty for travel, hotel, and per diem expenses. All accepted abstract presenters will be charged a $75 meeting registration fee and must complete a registration form to obtain a hotel reservation and meeting badge. This form, contained in the ACC.06 Advance Program, will be available in September; however, registrations in this category will not be accepted until Dec. 19, 2005. ACC members will automatically receive the brochure by mail. All others may request a copy: by e-mail resource@acc.org; by telephone 800-253-4636, ext. 694, or 301-897-2694 outside of North America; or fax 301-897-9745. Online meeting registration will be available to ACC members beginning Sept. 15 and to the general audience on Sept. 29. Please visit the ACC Web site on or after the dates listed to register online. Individuals who wish to register and secure housing before abstract notification should register in the appropriate category (member, nonmember, etc.) and then request a refund of overpaid fees if your abstract is accepted.
  • Abstract co-authors interested in finding out their acceptance status may access the ACC homepage, www.acc.org, beginning Dec. 19, 2005. During the week of Dec. 19, an e-mail will be sent to the person who submitted the abstract directing them to the abstract Web site to learn the disposition for each submission and to complete requested information for each accepted abstract.
  • General Information subject to change due to circumstances beyond the ACC’s control.

Policies

  1. Abstracts must be SUBMITTED BY 11:59 p.m. CT, ON WEDNESDAY, OCTOBER 5, 2005. The American College of Cardiology Foundation (ACCF) is not responsible for abstracts that are not submitted by this deadline date.
  2. Submissions with incomplete status cannot be processed.
  3. Submission of an abstract constitutes a commitment by the author(s) to present if accepted. Failure to present and register for the meeting, if not justified, will jeopardize future acceptance of abstracts.
  4. There is no limit to the number of abstracts an investigator may submit. If selected, the presenter must be one of the co-authors listed. An investigator may present no more than two abstracts. If more than two abstracts are accepted from an investigator, one of the co-authors must present any additional papers.
  5. Investigators should not submit the same research; abstracts that appear to be replicate versions of a single study will be rejected. The same paper should not be submitted to both the ACC.06 submission process and the i2 Summit 2006 submission process. Submissions will be checked for duplication and replicate versions will be rejected.
  6. Follow all instructions for completing the submission. Be sure to structure the content into Background, Methods, Results, and Conclusion sections.
  7. Clarity of expression will be considered in the review process. The overall quality of language used should assure comprehension by the reader.
  8. Use a maximum of five unique abbreviations in the body of the abstract. No abbreviations should appear in the title. Place abbreviations in parentheses after the full word the first time it appears. Abbreviations increase the difficulty of reading and evaluating abstracts, which will be considered in the review process.
  9. If authors' names appear on more than one abstract, their names must appear and be spelled identically on each abstract in order to facilitate proper indexing. Whenever possible, do not list authors with initials only.
  10. Submitters may return to the online system to edit abstracts, revise information, correct typographical errors, tables, graphics, or delete a submission at any time before 11:59 p.m. CT on October 5, 2005. After this time, the system will be closed, and abstracts will be forwarded for the reviewing process. An author may not revise or resubmit an abstract in order to make changes or corrections after this deadline; adding or removing authors is not permitted. The abstract may be withdrawn or, if accepted, the error may be indicated during the presentation. Proofread abstracts carefully to avoid errors before they are submitted. The ACCF is not authorized to make changes to a submission. This includes typographical errors. Your abstract, if selected, will be published in print and electronic versions exactly as submitted. Tables and graphics, if the quality submitted is poor, will also appear badly in print and electronic versions. If you choose to withdraw an abstract after the submission deadline, this request must be received by the ACCF in writing.
  11. Abstracts are not eligible for consideration if the paper has been presented at a U.S. national or international meeting held in North America before the ACC Annual Scientific Session.
  12. Abstracts are not eligible for consideration if the manuscript of the abstract has been published before the ACC Annual Scientific Session.
  13. Abstracts submitted to the Young Investigators Awards (YIA) Competition may also be submitted for ACC.06 consideration using the respective submission methods. If selected both as a YIA Competition finalist and as a presenter of an oral or poster presentation, an author must choose one forum for this abstract. Submission to the YIA Competition does not automatically enter the abstract in the ACC.06 abstract process. Click here for additional information regarding the YIA submission process.
  14. Any human experimentation must conform with the principles of the Declaration of Helsinki of the World Medical Association.
  15. The Annual Scientific Session Program Committee and the i2 Summit Steering Committee endorse the position of the American Association for the Advancement for Science in requiring assurances of the responsible use of animals in research. All submissions for consideration must be in compliance with the guidelines.
  16. Each presenting author will be asked to comply with the ACCF "Statement on Disclosure (Vested Interest) and Conflict of Interest for Accredited Educational Activities” Policy. Indication of the relationship, the associated commercial entity and level of support is required for each author at the time of submission. Again this year, all presenters at ACC.06 and the i2 Summit 2006 must display a slide (or equivalent if poster session) at the beginning of their presentation indicating disclosure information as applicable, or that they have nothing to disclose.
  17. The submitter acts on behalf of all co-authors and in submitting an abstract, transfers to the American College of Cardiology the copyright and all other rights in the material comprising the abstract if the abstract is accepted. Co-authors reserve the following: a) all proprietary rights other than copyright, such as patent rights; and b) the right to use all or part of the abstract in future works of their own. The American College of Cardiology, as holder of the copyright on the accepted abstract, reserves all rights of reproduction, distribution, performance, display, and the right to create derivative works in both print and digital formats.
  18. In light of increased attention to the manner is which research results (particularly those affecting the stock of publicly-traded companies) are made public, ACC is clarifying its policies and procedures regarding disclosure of abstracts. All abstracts submitted are disclosed to members of the peer review selection committee, as well as to ACC employees and contractors as necessary in connection with the annual meeting. Those abstracts that are accepted for presentation are published and are publicly available to the public in advance of the annual meeting. The usual procedures for publishing abstracts are set forth below under “Accepted Abstracts.” Abstracts not accepted for presentation are not published, and are ordinarily not disclosed outside of ACC and persons associated with the selection process (i.e., the peer review committee). Notwithstanding these policies and procedures, ACC is not subject to any confidentiality requirements with respect to submitted abstracts. In addition, compliance with any disclosure or nondisclosure requirements that apply to researchers or research sponsors (whether under federal securities laws, contract agreement, or otherwise) is the sole responsibility of the researcher and/or sponsor, and not the ACC.
  19. All authors must comply with the ACC embargo policy, which states that scientific study results to be presented during the Annual Scientific Session and i2 Summit must not be revealed to the public prior to the scheduled time of presentation at ACC.06/i2 Summit 2006 or the ACC news conference, whichever one comes first. This includes presentations at satellite meetings or press conferences held before the scheduled Annual Scientific Session scientific presentation. This also means that if media representatives contact abstract authors/presenters, information must be given with the understanding that material is under embargo until the time of presentation or ACC news conference to include the date and time. Abstract authors/presenters who ignore the embargo rules run the risk of being withdrawn from the program.

Accepted Abstracts

Titles and co-authors of accepted abstracts for oral and poster presentations will be listed in the onsite programs. Title and co-author listings will also be posted in the online Program Planner in December. Full text of accepted abstracts will be published in print and/or electronic versions of the Journal of the American College of Cardiology, and the online Program Planner in advance of the meeting.

The person submitting an accepted abstract will receive an e-mail in mid December. The submitter will be asked to reconfirm the name and contact information of the presenter or change it to one of the authors (in order to comply with the two-abstract presentation limit); and indicate audiovisual needs for oral presentations on the Presenter’s Agreement.

Oral Presentations

All oral presentations will be programmed into 15-minute time slots. Your Presenter’s Agreement will indicate the time of your session. You will have 10 minutes for presentation and three minutes for discussion. All abstract presentations, question, and answer periods will be in English. If you need assistance in understanding the questions or responding in English, you are encouraged to have the session co-chair or a member of your research group assist you.

ACC is committed to providing the audience and faculty the best education environment possible. The ACC uses an all-electronic format for audiovisual requirements. All meeting rooms utilizing audio visual equipment will be networked. Presentations will be downloaded from a central server and sent to the respective meeting room on a secured site. Presenters will be required to upload their presentation in advance; or bring their presentation in an electronic format to the Speaker Ready Room, where they will have the opportunity to review or make changes on computers in the room, and then give the okay for the presentation to be uploaded to the appropriate meeting room. This will allow presenters to leave their laptops in the hotel room (or at home) and will minimize distraction and critical time wasted for both the head table participants and the audience as well.

A listing of the audiovisual hardware/software provided in each of the education rooms will be indicated on the Presenter’s Agreement.

Poster Presentations

If your abstract is accepted as a poster, your Presenter’s Agreement will indicate the hour you are required to attend the board. Each light gray poster board measures four feet high (121 cm) and eight feet wide (244 cm). You must provide a copy of the abstract, typed in large type for posting on the board. Illustrations must be readable from distances of at least three feet. Use lightweight poster board only; heavy board is difficult to secure. Velcro fasteners and push pins will be available on site. All presentation materials should be made in advance and brought to the Annual Scientific Session/i2 Summit. No audiovisual, projection, or computer equipment requiring electrical power will be permitted in the general poster session area.

Other Poster Presentation Formats. ACC will be piloting a number of different formats at ACC.06 and i2 Summit 2006 that may include e-poster, moderated e-poster, moderated poster, and featured poster presentations. Your Presenter’s Agreement will indicate if you are accepted to present in one or more of these formats and will contain specific information regarding each.